Krystal Biotech (NASDAQ:KRYS) Stock Price Up 7.1% After Analyst Upgrade
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) rose 7.1% during mid-day trading on Thursday after Citigroup raised their price target on the stock from $206.00 to $215.00. Citigroup currently has a neutral rating on the stock. Krystal Biotech traded as high as $186.69 and last traded at $188.63. Approximately 82,372 shares changed […]
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) rose 7.1% during mid-day trading on Thursday after Citigroup raised their price target on the stock from $206.00 to $215.00. Citigroup currently has a neutral rating on the stock. Krystal Biotech traded as high as $186.69 and last traded at $188.63. Approximately 82,372 shares changed […]
